Home › Germany's Merck cautious after deal spree
 

Keywords :   


Germany's Merck cautious after deal spree

2015-03-03 10:15:59| Chemicals - Topix.net

Germany's Merck KGaA forecasts little or no improvement in earnings this year after a slight drop in fourth-quarter net profit, with stiff competition for its blockbuster multiple-sclerosis treatment and higher research spending likely to offset the impact of recent acquisitions. Multiple-sclerosis drug Rebif faces strong competition in North America and Europe while Merck continues to spend on developing new cancer treatments.

Tags: deal cautious merck spree

Category:Chemicals

Latest from this category

All news
15.06Weekly Recap: PPG, AkzoNobel, Hempel Top This Weeks Stories
14.06Chemours Publishes 2023 Sustainability Report
14.06CalPoly Hosts Polymers & Coatings Summer 2024 Short Course
14.06 OQ Chemicals Announces Price Increases for Carboxylic Acids
14.06PNWSCT CoatingsFest 24 Golf Tees Off Sept. 11
14.06BMG is Exclusive Distributor for Marabu Coatings in the US
13.06PCI Announces 2024 Scholarship Recipients
13.06Evonik Develops TEGO Therm Fire-Resistant Coatings for EVs
Chemicals »
15.06This Week in Agribusiness, June 15, 2024
15.06Atlantic Tropical Weather Outlook
15.06Eastern North Pacific Tropical Weather Outlook
15.06With Gratitude for a Job Well Done
15.06Weekly Recap: PPG, AkzoNobel, Hempel Top This Weeks Stories
15.06Atlantic Tropical Weather Outlook
15.06Eastern North Pacific Tropical Weather Outlook
15.06Atlantic Tropical Weather Outlook
More »